BIOA NASDAQ
BioAge Labs Inc.
1W: -1.6%
1M: -23.8%
3M: -75.3%
YTD: -57.4%
1Y: -28.0%
$5.47
+0.48 (+9.62%)
Weekly Expected Move ±10.0%
$4
$5
$5
$6
$6
Credit Risk of going bust: higher than 72% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-09-27
Earliest Filing
2024-09-27
Latest Filing
partner: 4
investor: 1
Counterparties (Filed by BIOA)
5 relationshipsCompanies named in BIOA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Sofinnova Venture Partners, XI, L.P. | — | investor | Purchased 588,888 shares of common stock in a private placement concurrent with the IPO. | 2024-09-27 | View |
| Goldman Sachs & Co. LLC | GSCE | partner | Acted as a placement agent for the private placement financing. | 2024-09-27 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Acted as a placement agent for the private placement financing. | 2024-09-27 | View |
| Jefferies LLC | JEF | partner | Acted as a placement agent for the private placement financing. | 2024-09-27 | View |
| Citigroup Global Markets Inc. | — | partner | Acted as a placement agent for the private placement financing. | 2024-09-27 | View |
Recent 8-K Filings (17)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Other Events | View | |
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-12 | Shareholder Vote | View | |
| 2026-05-08 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-01-22 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2026-01-20 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-04 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-09 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-04 | Other Events | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-09-27 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR